S E Booth

1.0k total citations
12 papers, 775 citations indexed

About

S E Booth is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, S E Booth has authored 12 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Physiology and 2 papers in Surgery. Recurrent topics in S E Booth's work include Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Alzheimer's disease research and treatments (5 papers) and Dermatological and Skeletal Disorders (2 papers). S E Booth is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Alzheimer's disease research and treatments (5 papers) and Dermatological and Skeletal Disorders (2 papers). S E Booth collaborates with scholars based in United Kingdom, South Africa and Canada. S E Booth's co-authors include Philip N. Hawkins, David R. Booth, Glenys A. Tennent, Tuğba Yavuzşen, Bülent Şengül, Müjde Soytürk, Servet Akar, A Bybee, J. Ruth Gallimore and Helen J. Lachmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Brain.

In The Last Decade

S E Booth

12 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S E Booth United Kingdom	9	660	190	163	156	138	12	775
S. Madhoo United Kingdom	9	464 0.7×	137 0.7×	80 0.5×	112 0.7×	106 0.8×	17	577
M.R. Persey United Kingdom	6	563 0.9×	28 0.1×	129 0.8×	130 0.8×	148 1.1×	13	658
Satoko Kinoshita Japan	8	667 1.0×	127 0.7×	53 0.3×	80 0.5×	589 4.3×	14	1.3k
Kiyoshi Takahashi Japan	12	199 0.3×	224 1.2×	60 0.4×	110 0.7×	51 0.4×	15	568
Hugh J. B. Goodman United Kingdom	12	666 1.0×	32 0.2×	48 0.3×	57 0.4×	158 1.1×	22	758
Monica Concardi Italy	8	216 0.3×	73 0.4×	51 0.3×	67 0.4×	48 0.3×	13	373
Eiichi Kinoshita Japan	16	411 0.6×	91 0.5×	27 0.2×	87 0.6×	42 0.3×	51	775
Gerald S. Spear United States	15	244 0.4×	50 0.3×	41 0.3×	112 0.7×	136 1.0×	38	693
Zhendong Ma United States	13	622 0.9×	130 0.7×	32 0.2×	99 0.6×	29 0.2×	13	915
Linda M. Ayer Canada	11	177 0.3×	223 1.2×	40 0.2×	34 0.2×	43 0.3×	16	569

Countries citing papers authored by S E Booth

Since Specialization

Citations

This map shows the geographic impact of S E Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S E Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S E Booth more than expected).

Fields of papers citing papers by S E Booth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S E Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S E Booth. The network helps show where S E Booth may publish in the future.

Co-authorship network of co-authors of S E Booth

This figure shows the co-authorship network connecting the top 25 collaborators of S E Booth. A scholar is included among the top collaborators of S E Booth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S E Booth. S E Booth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Pepys, Mark B., Glenys A. Tennent, David R. Booth, et al.. (2007). Molecular Mechanisms of Fibrillogenesis and the Protective Role of Amyloid P Component: Two Possible Avenues for Therapy. Novartis Foundation symposium. 199. 73–103. 3 indexed citations

Lachmann, Helen J., Bülent Şengül, Tuğba Yavuzşen, et al.. (2006). Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Lara D. Veeken. 45(6). 746–750. 286 indexed citations

Brett, Molly S., M.R. Persey, Mary M. Reilly, et al.. (1999). Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain. 122(2). 183–190. 91 indexed citations

Gillmore, JD, S E Booth, GA Tennent, et al.. (1998). Transthyretin Ile73Val is associated with familial amyloidotic polyneuropathy in a Bangladeshi family. Human Mutation. 12(2). 135–135. 8 indexed citations

Booth, David R., Shouyong Tan, S E Booth, et al.. (1996). Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.. Journal of Clinical Investigation. 97(12). 2714–2721. 75 indexed citations

Persey, M.R., David R. Booth, S E Booth, et al.. (1996). A New Deletion Mutation of the Apolipoprotein Ai Gene Causing Hereditary Amyloidosis. Clinical Science. 90(s34). 33P–33P. 4 indexed citations

Persey, M.R., Laurence Lovat, David R. Booth, et al.. (1996). TTR mutations in 2 patients wtph a clinical diagnosis of senile cardiac amyloidosis. Neuromuscular Disorders. 6. S22–S22. 1 indexed citations

Booth, David R., S E Booth, M.R. Persey, et al.. (1996). 3 New amyloidogenic TTR mutations: Pro12, Glu18, and Val33. Neuromuscular Disorders. 6. S20–S20. 8 indexed citations

Booth, David R., Shouyong Tan, S E Booth, et al.. (1995). A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis. QJM. 88(10). 695–702. 59 indexed citations

10.

Pepys, Mark B., S E Booth, Glenys A. Tennent, P.J.G. Butler, & David G. Williams. (1994). Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clinical & Experimental Immunology. 97(1). 152–157. 78 indexed citations

11.

Vigushin, David M., J Gough, Donald R. Allan, et al.. (1994). Familial nephropathic systemic amyloidosis caused by apolipoprotein Al variant Arg26. QJM. 87(3). 149–54. 47 indexed citations

12.

Soutar, Anne K., Philip N. Hawkins, David M. Vigushin, et al.. (1992). Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.. Proceedings of the National Academy of Sciences. 89(16). 7389–7393. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact